Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1995
A Monte Carlo simulation model for radiation dose to metastatic skeletal tumor from rhenium-186(Sn)-HEDPR C Samaratunga, S R Thomas, J D Hinnefeld, et al.
Advances in Experimental Medicine and Biology|January 1, 1984
Perfluorinated organic liquids and emulsions as biocompatible NMR imaging agents for 19F and dissolved oxygenL C Clark, J L Ackerman, S R Thomas, et al.
Radiology|January 1, 1978
Dose to the metaphyseal growth complexes in children undergoing 99mTc-EHDP bone scansS R Thomas, M J Gelfand, J G Kereiakes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 1998
Rhenium-188(Sn)HEDP for treatment of osseous metastasesH R Maxon, L E Schroder, L C Washburn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1991
Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placeboH R Maxon, L E Schroder, V S Hertzberg, et al.
Seminars in Nuclear Medicine|January 1, 1992
Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastasesH R Maxon, S R Thomas, V S Hertzberg, et al.
Oncogene|November 23, 2011
PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signalingY Shrestha, E J Schafer, J S Boehm, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 1999
The MIRD perspective 1999. Medical Internal Radiation Dose CommitteeR W Howell, B W Wessels, R Loevinger, et al.
Pageof 19